RPG Life Sciences Limited

₹2,579As of Sun 8 Nov 2026, 12:00 UTC
NSE:RPGLIFEHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 19.74%
Div yield 0.93%
ROE 15.60%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.05)
PE TTM 38.52
TSR TTM 8.34%
Mkt cap ₹42.65B
ROIC 20.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,644
2.52%
(36.41%)
Hold 6|3|9|12|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
36.29
36.26
40.02
42.64
0.58%
4.04%
12.29%
20.37%
Revenue₹B
2.242
2.371
2.432
2.517
2.75%
11.22%
8.29%
9.58%
Peers (US$450.8M)
Cap (US$)
PE
459.3M
58.86x
433.3M
17.80x
450.4M
—
Capital
TTM
5Y
10Y
Leveragex
4.093
0.022
0.022
EBIT/Intx
4.340
0.244
0.211
Own earn%
(82.05)
(94.90)
(86.47)
Sh yield%
30.59
58.45
55.55
Owners
Insiders/Inst%
14.58
35.64
Short interest%
4.76
SBC / revenue%
1.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
18–30
$1 testx
0.0
Incr. ROIC%
21